Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Burger

Showing results (121-130 of 132) with videos related to

Pageof 14
Sort By:
Clinical Pharmacology and Therapeutics|March 3, 2007
Age-dependent pharmacokinetics of lamivudine in HIV-infected childrenD M Burger, G Verweel, N Rakhmanina, et al.
AIDS (London, England)|June 5, 1999
Randomized trial comparing saquinavir soft gelatin capsules versus indinavir as part of triple therapy (CHEESE study)J W Cohen Stuart, R Schuurman, D M Burger, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 10, 2001
A retrospective, cohort-based survey of patients using twice-daily indinavir + ritonavir combinations: pharmacokinetics, safety, and efficacyD M Burger, P W Hugen, R E Aarnoutse, et al.
The Journal of Antimicrobial Chemotherapy|February 5, 2021
The dolutegravir/valproic acid drug-drug interaction is primarily based on protein displacementP D J Bollen, H A B Prins, A Colbers, et al.
The Journal of Pediatrics|June 6, 2000
Clinical and virologic response to combination treatment with indinavir, zidovudine, and lamivudine in children with human immunodeficiency virus-1 infection: a multicenter study in the Netherlands. On behalf of the Dutch Study Group for Children with HIV-1 infectionsA M van Rossum, H G Niesters, S P Geelen, et al.
HIV Medicine|May 7, 2024
De-simplifying antiretroviral therapy from a single-tablet to a two-tablet regimen: Acceptance, patient-reported outcomes, and cost savings in a multicentre studyP Oosterhof, B G J A de Zoete, J W Vanhommerig, et al.
Alimentary Pharmacology & Therapeutics|September 8, 2017
Ribavirin steady-state plasma level is a predictor of sustained virological response in hepatitis C-infected patients treated with direct-acting antiviralsM van Tilborg, F I Lieveld, E J Smolders, et al.
Archives of Internal Medicine|September 26, 2001
Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort studyP T Nieuwkerk, M A Sprangers, D M Burger, et al.
HIV Medicine|August 30, 2008
The effect of cholecalciferol supplementation on vitamin D levels and insulin sensitivity is dose related in vitamin D-deficient HIV-1-infected patientsC J P van den Bout-van den Beukel, M van den Bos, W J G Oyen, et al.
The Netherlands Journal of Medicine|September 11, 2019
Retrieval of chronic hepatitis C patients. A manifesto for action to eliminate hepatitis C in the Netherlands: the CELINE projectM van Dijk, P A M Kracht, J E Arends, et al.
Pageof 14

Showing results (121-130 of 132) with videos related to

Sort By:
Pageof 14
Clinical Pharmacology and Therapeutics|March 3, 2007
Age-dependent pharmacokinetics of lamivudine in HIV-infected childrenD M Burger, G Verweel, N Rakhmanina, et al.
AIDS (London, England)|June 5, 1999
Randomized trial comparing saquinavir soft gelatin capsules versus indinavir as part of triple therapy (CHEESE study)J W Cohen Stuart, R Schuurman, D M Burger, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 10, 2001
A retrospective, cohort-based survey of patients using twice-daily indinavir + ritonavir combinations: pharmacokinetics, safety, and efficacyD M Burger, P W Hugen, R E Aarnoutse, et al.
The Journal of Antimicrobial Chemotherapy|February 5, 2021
The dolutegravir/valproic acid drug-drug interaction is primarily based on protein displacementP D J Bollen, H A B Prins, A Colbers, et al.
The Journal of Pediatrics|June 6, 2000
Clinical and virologic response to combination treatment with indinavir, zidovudine, and lamivudine in children with human immunodeficiency virus-1 infection: a multicenter study in the Netherlands. On behalf of the Dutch Study Group for Children with HIV-1 infectionsA M van Rossum, H G Niesters, S P Geelen, et al.
HIV Medicine|May 7, 2024
De-simplifying antiretroviral therapy from a single-tablet to a two-tablet regimen: Acceptance, patient-reported outcomes, and cost savings in a multicentre studyP Oosterhof, B G J A de Zoete, J W Vanhommerig, et al.
Alimentary Pharmacology & Therapeutics|September 8, 2017
Ribavirin steady-state plasma level is a predictor of sustained virological response in hepatitis C-infected patients treated with direct-acting antiviralsM van Tilborg, F I Lieveld, E J Smolders, et al.
Archives of Internal Medicine|September 26, 2001
Limited patient adherence to highly active antiretroviral therapy for HIV-1 infection in an observational cohort studyP T Nieuwkerk, M A Sprangers, D M Burger, et al.
HIV Medicine|August 30, 2008
The effect of cholecalciferol supplementation on vitamin D levels and insulin sensitivity is dose related in vitamin D-deficient HIV-1-infected patientsC J P van den Bout-van den Beukel, M van den Bos, W J G Oyen, et al.
The Netherlands Journal of Medicine|September 11, 2019
Retrieval of chronic hepatitis C patients. A manifesto for action to eliminate hepatitis C in the Netherlands: the CELINE projectM van Dijk, P A M Kracht, J E Arends, et al.
Pageof 14